The five D's of botulinum toxin: Doses, dilution, diffusion, duration and dogma

References

• Morgan J. C., Iyer S. S., Moser E. T., Singer C., Sethi K. D. Botulinum toxin A during pregnancy: A survey of treating physicians. J Neurol Neurosurg Psychiatry 2006; 77: 117–19
   PubMed Web of Science ®Google Scholar
• De Oliveira Monteiro E. Botulinum toxin and pregnancy. Skinmed 2006; 5: 308
   PubMedGoogle Scholar
• Ward S. J., Harrop‐Griffiths W. Botox injections and monitoring neuromuscular blockade. Anaesthesia 2006; 61: 726
   PubMed Web of Science ®Google Scholar
• Klein A. W. Dilution and storage of botulinum toxin. Dermatol Surg 1998; 24: 1179–80
   PubMed Web of Science ®Google Scholar
• Hankins C. L., Strimling R., Rogers G. S. Botulinum A toxin for glabellar wrinkles. Dose and Response. Dermatol Surg 1998; 24: 1181–3
   PubMed Web of Science ®Google Scholar
• Trindade De Almeida A. R., Kadunc B. V., Di Chiacchio N., Neto D. R. Foam during reconstitution does not affect the potency of Botulinum toxin. Dermatol Surg 2003; 29: 530–1
   PubMed Web of Science ®Google Scholar
• Alam M., Yoo S. S., Wrone D. A., White L. E., Kim J. Y. Sterility assessment of multiple use botulinum A exotoxin vials: A prospective simulation. J Am Acad Dermatol 2006; 55: 272–5
   PubMed Web of Science ®Google Scholar
• Hexsel D. M., De Almeida A. T., Rutowitsch M., De Castro I. A., Silveira V. L., Gobatto D. O., et al. Multicenter, double‐blind study of the efficacy of injections with botulinum toxin reconstituted up to six consecutive weeks before application. Dermatol Surg 2003; 29: 523–9
   PubMed Web of Science ®Google Scholar
• Carruthers A., Carruthers J., Cohen J. Dilution volume of botulinum toxin for the treatment of glabellar rhytides: Does it matter?. Dermatol Surg 2007; 33: S97–S104
   PubMed Web of Science ®Google Scholar
• Hsu T. S., Dover J. S., Arndt K. A. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 2004; 140: 1351–4
   PubMed Web of Science ®Google Scholar
• Carruthers A., Bogle M., Carruthers J. D., Dover J. S., Arndt K. A., Hsu T. S., et al. A randomized, evaluator‐blinded, two‐center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin in the treatment of lateral orbital rhytides. Dermatol Surg 2007; 33: 567–71
   PubMed Web of Science ®Google Scholar
• Flynn T. C., Carruthers A., Carruthers J. Surgical pearl: The use of the Ultra‐Fine II short needle 0.3‐cc insulin syringe for botulinum toxin injections. J Am Acad Dermatol 2002; 46: 931–3
   PubMed Web of Science ®Google Scholar
• Alam M., Dover J. S., Arndt K. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative. Arch Dermatol 2002; 138: 510–14
   PubMedGoogle Scholar
• Kwiat D. M., Bersani T. A., Bersani A. Increased patient comfort utilizing botulinum toxin reconstituted with preserved versus nonpreserved saline. Ophthal Plast Reconstr Surg 2004; 20: 186–9
   PubMed Web of Science ®Google Scholar
• Vadoud‐Seyedi J., Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin reconstituted in lidocaine or in normal saline: A randomized, side‐by‐side, double‐blind study. Br J Dermatol 2007; 156: 986–9
   PubMed Web of Science ®Google Scholar
• Pena M. A., Alam M., Yoo S. S. Complications with the use of botulinum toxin for cosmetic applications and hyperhidrosis. Semin Cutan Med Surg 2007; 26: 29–33
   PubMed Web of Science ®Google Scholar
• Carruthers A., Carruthers J., Samireh S. Dose‐ranging study of botulinum toxin in the treatment of glabellar rhytids in females. Dermatol Surg 2005; 31: 414–22
   PubMed Web of Science ®Google Scholar
• Carruthers J., Fagien S., Matarasso S. L., the Botox Consensus Group. Consensus recommendations on the use of botulinum toxin in facial aesthetics. Plast Reconstr Surg 2004; 114: 1S–22S
   PubMed Web of Science ®Google Scholar
• Carruthers A., Carruthers J. Prospective, double‐blind, randomized, parallel‐group, dose‐ranging study of botulinum toxin type A in men with glabellar rhytids. 2005; 31: 1297–303
   Google Scholar
• Levy J. L., Pons F., Jouve E. Management of the ageing eyebrow and forehead: An objective dose‐‐response study with botulimun toxin. J Eur Acad Dermatol Venereol 2006; 20: 711–16
   PubMed Web of Science ®Google Scholar
• Carruthers A., Carruthers J., Cohen J. A prospective, double‐blind, randomized, parallel‐group, dose‐ranging study of botulinum toxin in female subjects with horizontal forehead rhytides. Dermatol Surg 2003; 29: 461–7
   PubMed Web of Science ®Google Scholar
• Balikian R. V., Zimbler M. S. Primary and adjunctive uses of botulinum toxin in the periorbital region. Otolaryngol Clin North Am 2007; 40: 291–303
   PubMed Web of Science ®Google Scholar
• Carruthers A., Carruthers J. Eyebrow height after botulinum toxin to the glabella. Dermatol Surg 2007; 33: S26–S31
   Web of Science ®Google Scholar
• Ahn M. S., Catten M., Maas C. S. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg 2000; 105: 1129–35
   PubMed Web of Science ®Google Scholar
• Lowe N. J., Lask G., Yamauchi P., Moore D. Bilateral, double‐blind, randomized comparison of 3 doses of botulinum toxin and placebo in patients with crow's feet. J Am Acad Dermatol 2002; 47: 834–40
   PubMed Web of Science ®Google Scholar
• Lowe N. J., Ascher B., Heckmann M., Kumar C., Fraczek S., Eadie N., et al. Botox facial aesthetics study team. Double‐blind, randomized, placebo‐controlled, dose–response study of the safety and efficacy of botulinum toxin in subjects with crow's feet. Dermatol Surg 2005; 31: 257–62
   PubMed Web of Science ®Google Scholar
• Paloma V., Samper A. A complication with aesthetic use of Botox: Herniation of the orbital fat. Plast Reconstr Surg 2001; 107: 1315–16
   PubMed Web of Science ®Google Scholar
• Flynn T. C., Carruthers J., Carruthers A. Botulinum‐A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 2001; 27: 703–8
   PubMed Web of Science ®Google Scholar
• Flynn T. C., Carruthers J., Carruthers A., Clark II R. E. Botulinum A toxin (BOTOX) in the lower eyelid: Dose‐finding study. Dermatol Surg 2003; 29: 943–51
   PubMed Web of Science ®Google Scholar
• Carruthers J., Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg 2003; 29: 468–76
   PubMed Web of Science ®Google Scholar
• Semchyshyn N., Sengelmann R. D. Botulinum toxin A treatment of perioral rhytides. Dermatol Surg 2003; 29: 490–5
   PubMed Web of Science ®Google Scholar
• Brandt F. S., Boker A. Botulinum toxin for the treatment of neck lines and neck bands. Dermatol Clin 2004; 22: 159–66
   PubMed Web of Science ®Google Scholar
• Matarasso A., Matarasso S. L., Brandt F. S., Bellman B. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 1999; 103: 645–52
   PubMed Web of Science ®Google Scholar
• Kane M. A. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast Reconstr Surg 1999; 103: 656–63
   PubMed Web of Science ®Google Scholar
• Huang W., Foster J. A., Rogachefsky A. S. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000; 43: 240–59
   Web of Science ®Google Scholar
• Hsu T., Dover J. S., Kaminer M. S., Arndt K. A., Tan M. Why make patients exercise facial muscles for 4 hours after botulinum toxin treatment?. Arch Dermatol 2003; 139: 948
   PubMedGoogle Scholar